ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage

REFERENCES

• Ababou, M., Dutertre S., Lecluse Y., Onclercq R., Chatton B., and Amor-Gueret M.. 2000. ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. Oncogene 19:5955–5963.
   PubMedGoogle Scholar
• Abraham, R. T. 2003. Checkpoint signaling: epigenetic events sound the DNA strand-breaks alarm to the ATM protein kinase. BioEssays 25:627–630.
   PubMedGoogle Scholar
• Adamson, A. W., Kim W. J., Shangary S., Baskaran R., and Brown K. D.. 2002. ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation. J. Biol. Chem. 277:38222–38229.
   PubMed Web of Science ®Google Scholar
• Banin, S., Moyal L., Shieh S., Taya Y., Anderson C. W., Chessa L., Smorodinsky N. I., Prives C., Reiss Y., Shiloh Y., and Ziv Y.. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677.
   PubMed Web of Science ®Google Scholar
• Blattner, C., Sparks A., and Lane D.. 1999. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell. Biol. 19:3704–3713.
   PubMed Web of Science ®Google Scholar
• Brown, K. D., Rathi A., Kamath R., Beardsley D. I., Zhan Q., Mannino J. L., and Baskaran R.. 2003. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33:80–84.
   PubMedGoogle Scholar
• Brummelkamp, T. R., Bernards R., and Agami R.. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Buermeyer, A. B., Wilson-Van Patten C., Baker S. M., and Liskay R. M.. 1999. The human MLH1 cDNA complements DNA mismatch repair defects in Mlh1-deficient mouse embryonic fibroblasts. Cancer Res. 59:538–541.
   PubMedGoogle Scholar
• Bunz, F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J. P., Sedivy J. M., Kinzler K. W., and Vogelstein B.. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497–1501.
   PubMed Web of Science ®Google Scholar
• Canman, C. E., Lim D. S., Cimprich K. A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M. B., and Siliciano J. D.. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1679.
   PubMed Web of Science ®Google Scholar
• Carmo-Fonseca, M. 2002. The contribution of nuclear compartmentalization to gene regulation. Cell 108:513–521.
   PubMedGoogle Scholar
• Cejka, P., Stojic L., Mojas N., Russell A. M., Heinimann K., Cannavo E., di Pietro M., Marra G., and Jiricny J.. 2003. Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 22:2245–2254.
   PubMed Web of Science ®Google Scholar
• Chang, D. K., Ricciardiello L., Goel A., Chang C. L., and Boland C. R.. 2000. Steady-state regulation of the human DNA mismatch repair system. J. Biol. Chem. 275:29178.
   PubMedGoogle Scholar
• Chehab, N. H., Malikzay A., Appel M., and Halazonetis T. D.. 2000. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 14:278–288.
   PubMed Web of Science ®Google Scholar
• Duckett, D. R., Bronstein S. M., Taya Y., and Modrich P.. 1999. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl. Acad. Sci. USA 96:12384–12388.
   PubMedGoogle Scholar
• Dumaz, N., and Meek D. W.. 1999. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18:7002–7010.
   PubMed Web of Science ®Google Scholar
• Durant, S. T., Morris M. M., Illand M., McKay H. J., McCormick C., Hirst G. L., Borts R. H., and Brown R.. 1999. Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. Curr. Biol. 9:51–54.
   PubMed Web of Science ®Google Scholar
• Fishel, R. 1999. Signaling mismatch repair in cancer. Nat. Med. 5:1239–1241.
   PubMed Web of Science ®Google Scholar
• Flores-Rozas, H., and Kolodner R. D.. 1998. The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations. Proc. Natl. Acad. Sci. USA 95:12404–12409.
   PubMedGoogle Scholar
• Gong, J. G., Costanzo A., Yang H. Q., Melino G., Kaelin W. G., Jr., Levrero M., and Wang J. Y.. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806–809.
   PubMed Web of Science ®Google Scholar
• Gradia, S., Subramanian D., Wilson T., Acharya S., Makhov A., Griffith J., and Fishel R.. 1999. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol. Cell 3:255–261.
   PubMed Web of Science ®Google Scholar
• Harfe, B. D., Minesinger B. K., and Jinks-Robertson S.. 2000. Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast. Curr. Biol. 10:145–148.
   PubMedGoogle Scholar
• Hirao, A., Kong Y. Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S. J., and Mak T. W.. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824–1827.
   PubMed Web of Science ®Google Scholar
• Jallepalli, P. V., Lengauer C., Vogelstein B., and Bunz F.. 2003. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278:20475–20479.
   PubMedGoogle Scholar
• Kastan, M. B., Lim D. S., Kim S. T., and Yang D.. 2001. ATM—a key determinant of multiple cellular responses to irradiation. Acta Oncol. 40:686–688.
   PubMedGoogle Scholar
• Keramaris, E., Hirao A., Slack R. S., Mak T. W., and Park D. S.. 2003. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. J. Biol. Chem. 278:37782–37789. [Online.]
   PubMed Web of Science ®Google Scholar
• Kolodner, R. D., and Marsischky G. T.. 1999. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:89–96.
   PubMed Web of Science ®Google Scholar
• Leung, W. K., Kim J. J., Wu L., Sepulveda J. L., and Sepulveda A. R.. 2000. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J. Biol. Chem. 275:15728–15732.
   PubMedGoogle Scholar
• Lim, D. S., Kim S. T., Xu B., Maser R. S., Lin J., Petrini J. H., and Kastan M. B.. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613–617.
   PubMed Web of Science ®Google Scholar
• Lin, W. C., Lin F. T., and Nevins J. R.. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15:1833–1844.
   PubMed Web of Science ®Google Scholar
• Liu, T., Yan H., Kuismanen S., Percesepe A., Bisgaard M. L., Pedroni M., Benatti P., Kinzler K. W., Vogelstein B., Ponz de Leon M., Peltomaki P., and Lindblom A.. 2001. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 61:7798–7802.
   PubMed Web of Science ®Google Scholar
• Pedrazzi, G., Perrera C., Blaser H., Kuster P., Marra G., Davies S. L., Ryu G. H., Freire R., Hickson I. D., Jiricny J., and Stagljar I.. 2001. Direct association of Bloom's syndrome gene product with the human mismatch repair protein MLH1. Nucleic Acids Res. 29:4378–4386.
   PubMedGoogle Scholar
• Peters, A. C., Young L. C., Maeda T., Tron V. A., and Andrew S. E.. 2003. Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation. DNA Repair (Amsterdam) 2:427–435.
   PubMed Web of Science ®Google Scholar
• Prolla, T. A., Baker S. M., Harris A. C., Tsao J. L., Yao X., Bronner C. E., Zheng B., Gordon M., Reneker J., Arnheim N., Shibata D., Bradley A., and Liskay R. M.. 1998. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18:276–279.
   PubMed Web of Science ®Google Scholar
• Raschle, M., Marra G., Nystrom-Lahti M., Schar P., and Jiricny J.. 1999. Identification of hMutLβ, a heterodimer of hMLH1 and hPMS1. J. Biol. Chem. 274:32368–32375.
   PubMedGoogle Scholar
• Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155–168.
   PubMed Web of Science ®Google Scholar
• Shimodaira, H., Yoshioka-Yamashita A., Kolodner R. D., and Wang J. Y.. 2003. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. USA 100:2420–2425.
   PubMed Web of Science ®Google Scholar
• Stevens, C., Smith L., and La Thangue N. B.. 2003. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5:401–409.
   PubMed Web of Science ®Google Scholar
• Wang, T. F., Kleckner N., and Hunter N.. 1999. Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction. Proc. Natl. Acad. Sci. USA 96:13914–13919.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Cortez D., Yazdi P., Neff N., Elledge S. J., and Qin J.. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:927–939.
   PubMed Web of Science ®Google Scholar
• Wu, X., Platt J. L., and Cascalho M.. 2003. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLα. Mol. Cell. Biol. 23:3320–3328.
   PubMed Web of Science ®Google Scholar
• Xiong, W., and Ferrell J. E., Jr. 2003. A positive-feedback-based bistable ′memory module' that governs a cell fate decision. Nature 426:460–465.
   PubMed Web of Science ®Google Scholar
• Yanamadala, S., and Ljungman M.. 2003. Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates. Mol. Cancer Res. 1:747–754.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and Xiong Y.. 2001. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292:1910–1915.
   PubMed Web of Science ®Google Scholar
• Zink, D., Mayr C., Janz C., and Wiesmuller L.. 2002. Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene 21:4788–4800.
   PubMed Web of Science ®Google Scholar
• Ziv, Y., Bar-Shira A., Pecker I., Russell P., Jorgensen T. J., Tsarfati I., and Shiloh Y.. 1997. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15:159–167.
   PubMed Web of Science ®Google Scholar